Global HIV Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global HIV Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global HIV Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Multi-Class Combination Products
1.2.3 Nucleoside Reverse Transcriptase Inhibitors
1.2.4 Non-Nucleoside Reverse Transcriptase Inhibitors
1.2.5 Protease Inhibitors
1.2.6 Fusion Inhibitors
1.2.7 Entry Inhibitors - CCR5 Co-Receptor Antagonist
1.2.8 HIV Integrase Strand Transfer Inhibitors
1.3 Market Segment by Application
1.3.1 Global HIV Drugs Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global HIV Drugs Market Size (2017-2028)
2.1.1 Global HIV Drugs Revenue (2017-2028)
2.1.2 Global HIV Drugs Sales (2017-2028)
2.2 Global HIV Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global HIV Drugs Sales by Regions (2017-2022)
2.2.2 Global HIV Drugs Revenue by Regions (2017-2022)
2.3 Global HIV Drugs Market Size Forecast by Region
2.3.1 Global HIV Drugs Sales Forecast by Region (2023-2028)
2.3.2 Global HIV Drugs Revenue Forecast by Region (2023-2028)
2.4 Global Top HIV Drugs Regions (Countries) Ranking by Market Size
2.5 HIV Drugs Market Dynamics
2.5.1 HIV Drugs Market Trends
2.5.2 HIV Drugs Market Drivers
2.5.3 HIV Drugs Market Challenges
2.5.4 HIV Drugs Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top HIV Drugs Manufacturers by Sales (2017-2022)
3.1.1 Global HIV Drugs Sales by Manufacturers (2017-2022)
3.1.2 Global HIV Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by HIV Drugs Sales in 2021
3.2 Global Top Manufacturers HIV Drugs by Revenue
3.2.1 Global HIV Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Top HIV Drugs Manufacturers Covered: Ranking by Revenue
3.2.3 Global HIV Drugs Revenue Share by Manufacturers (2017-2022)
3.2.4 Global HIV Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV Drugs as of 2021)
3.4 Global HIV Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers HIV Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into HIV Drugs Market
3.7 Key Manufacturers HIV Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global HIV Drugs Market Size by Type
4.1 Global HIV Drugs Historic Market Review by Type (2017-2022)
4.1.1 Global HIV Drugs Sales Market Share by Type (2017-2022)
4.1.2 Global HIV Drugs Revenue Market Share by Type (2017-2022)
4.1.3 HIV Drugs Price by Type (2017-2022)
4.2 Global HIV Drugs Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global HIV Drugs Sales Forecast by Type (2023-2028)
4.2.2 Global HIV Drugs Revenue Forecast by Type (2023-2028)
4.2.3 HIV Drugs Price Forecast by Type (2023-2028)
5 Global HIV Drugs Market Size by Application
5.1 Global HIV Drugs Historic Market Review by Application (2017-2022)
5.1.1 Global HIV Drugs Sales Market Share by Application (2017-2022)
5.1.2 Global HIV Drugs Revenue Market Share by Application (2017-2022)
5.1.3 HIV Drugs Price by Application (2017-2022)
5.2 Global HIV Drugs Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global HIV Drugs Sales Forecast by Application (2023-2028)
5.2.2 Global HIV Drugs Revenue Forecast by Application (2023-2028)
5.2.3 HIV Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America HIV Drugs Sales Breakdown by Company
6.1.1 North America HIV Drugs Sales by Company (2017-2022)
6.1.2 North America HIV Drugs Revenue by Company (2017-2022)
6.2 North America HIV Drugs Market Size by Type
6.2.1 North America HIV Drugs Sales by Type (2017-2028)
6.2.2 North America HIV Drugs Revenue by Type (2017-2028)
6.3 North America HIV Drugs Market Size by Application
6.3.1 North America HIV Drugs Sales by Application (2017-2028)
6.3.2 North America HIV Drugs Revenue by Application (2017-2028)
6.4 North America HIV Drugs Market Size by Country
6.4.1 North America HIV Drugs Sales by Country (2017-2028)
6.4.2 North America HIV Drugs Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe HIV Drugs Sales Breakdown by Company
7.1.1 Europe HIV Drugs Sales by Company (2017-2022)
7.1.2 Europe HIV Drugs Revenue by Company (2017-2022)
7.2 Europe HIV Drugs Market Size by Type
7.2.1 Europe HIV Drugs Sales by Type (2017-2028)
7.2.2 Europe HIV Drugs Revenue by Type (2017-2028)
7.3 Europe HIV Drugs Market Size by Application
7.3.1 Europe HIV Drugs Sales by Application (2017-2028)
7.3.2 Europe HIV Drugs Revenue by Application (2017-2028)
7.4 Europe HIV Drugs Market Size by Country
7.4.1 Europe HIV Drugs Sales by Country (2017-2028)
7.4.2 Europe HIV Drugs Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific HIV Drugs Sales Breakdown by Company
8.1.1 Asia Pacific HIV Drugs Sales by Company (2017-2022)
8.1.2 Asia Pacific HIV Drugs Revenue by Company (2017-2022)
8.2 Asia Pacific HIV Drugs Market Size by Type
8.2.1 Asia Pacific HIV Drugs Sales by Type (2017-2028)
8.2.2 Asia Pacific HIV Drugs Revenue by Type (2017-2028)
8.3 Asia Pacific HIV Drugs Market Size by Application
8.3.1 Asia Pacific HIV Drugs Sales by Application (2017-2028)
8.3.2 Asia Pacific HIV Drugs Revenue by Application (2017-2028)
8.4 Asia Pacific HIV Drugs Market Size by Region
8.4.1 Asia Pacific HIV Drugs Sales by Region
8.4.2 Asia Pacific HIV Drugs Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America HIV Drugs Sales Breakdown by Company
9.1.1 Latin America HIV Drugs Sales by Company (2017-2022)
9.1.2 Latin America HIV Drugs Revenue by Company (2017-2022)
9.2 Latin America HIV Drugs Market Size by Type
9.2.1 Latin America HIV Drugs Sales by Type (2017-2028)
9.2.2 Latin America HIV Drugs Revenue by Type (2017-2028)
9.3 Latin America HIV Drugs Market Size by Application
9.3.1 Latin America HIV Drugs Sales by Application (2017-2028)
9.3.2 Latin America HIV Drugs Revenue by Application (2017-2028)
9.4 Latin America HIV Drugs Market Size by Country
9.4.1 Latin America HIV Drugs Sales by Country (2017-2028)
9.4.2 Latin America HIV Drugs Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa HIV Drugs Sales Breakdown by Company
10.1.1 Middle East and Africa HIV Drugs Sales by Company (2017-2022)
10.1.2 Middle East and Africa HIV Drugs Revenue by Company (2017-2022)
10.2 Middle East and Africa HIV Drugs Market Size by Type
10.2.1 Middle East and Africa HIV Drugs Sales by Type (2017-2028)
10.2.2 Middle East and Africa HIV Drugs Revenue by Type (2017-2028)
10.3 Middle East and Africa HIV Drugs Market Size by Application
10.3.1 Middle East and Africa HIV Drugs Sales by Application (2017-2028)
10.3.2 Middle East and Africa HIV Drugs Revenue by Application (2017-2028)
10.4 Middle East and Africa HIV Drugs Market Size by Country
10.4.1 Middle East and Africa HIV Drugs Sales by Country (2017-2028)
10.4.2 Middle East and Africa HIV Drugs Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Overview
11.1.3 Bristol-Myers Squibb HIV Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Bristol-Myers Squibb HIV Drugs Products and Services
11.1.5 Bristol-Myers Squibb HIV Drugs SWOT Analysis
11.1.6 Bristol-Myers Squibb Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Corporation Information
11.2.2 Gilead Sciences Overview
11.2.3 Gilead Sciences HIV Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Gilead Sciences HIV Drugs Products and Services
11.2.5 Gilead Sciences HIV Drugs SWOT Analysis
11.2.6 Gilead Sciences Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline HIV Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 GlaxoSmithKline HIV Drugs Products and Services
11.3.5 GlaxoSmithKline HIV Drugs SWOT Analysis
11.3.6 GlaxoSmithKline Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson HIV Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Johnson & Johnson HIV Drugs Products and Services
11.4.5 Johnson & Johnson HIV Drugs SWOT Analysis
11.4.6 Johnson & Johnson Recent Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Overview
11.5.3 Merck HIV Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Merck HIV Drugs Products and Services
11.5.5 Merck HIV Drugs SWOT Analysis
11.5.6 Merck Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 HIV Drugs Value Chain Analysis
12.2 HIV Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 HIV Drugs Production Mode & Process
12.4 HIV Drugs Sales and Marketing
12.4.1 HIV Drugs Sales Channels
12.4.2 HIV Drugs Distributors
12.5 HIV Drugs Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global HIV Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Multi-Class Combination Products
Table 3. Major Manufacturers of Nucleoside Reverse Transcriptase Inhibitors
Table 4. Major Manufacturers of Non-Nucleoside Reverse Transcriptase Inhibitors
Table 5. Major Manufacturers of Protease Inhibitors
Table 6. Major Manufacturers of Fusion Inhibitors
Table 7. Major Manufacturers of Entry Inhibitors - CCR5 Co-Receptor Antagonist
Table 8. Major Manufacturers of HIV Integrase Strand Transfer Inhibitors
Table 9. Global HIV Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global HIV Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 11. Global HIV Drugs Sales by Region (2017-2022) & (K Units)
Table 12. Global HIV Drugs Sales Market Share by Region (2017-2022)
Table 13. Global HIV Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global HIV Drugs Revenue Market Share by Region (2017-2022)
Table 15. Global HIV Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 16. Global HIV Drugs Sales Market Share Forecast by Region (2023-2028)
Table 17. Global HIV Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 18. Global HIV Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 19. Top HIV Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 20. HIV Drugs Market Trends
Table 21. HIV Drugs Market Drivers
Table 22. HIV Drugs Market Challenges
Table 23. HIV Drugs Market Restraints
Table 24. Global HIV Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 25. Global HIV Drugs Sales Share by Manufacturers (2017-2022)
Table 26. Global HIV Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 27. Ranking of Global Top HIV Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 28. HIV Drugs Revenue Share by Manufacturers (2017-2022)
Table 29. Global HIV Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV Drugs as of 2021)
Table 31. Key Manufacturers HIV Drugs Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 32. Key Manufacturers HIV Drugs Plants/Factories Distribution
Table 33. Key Manufacturers HIV Drugs Area Served
Table 34. Date of Key Manufacturers Enter into HIV Drugs Market
Table 35. Key Manufacturers HIV Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global HIV Drugs Sales (K Units) by Type (2017-2022)
Table 38. Global HIV Drugs Sales Share by Type (2017-2022)
Table 39. Global HIV Drugs Revenue (US$ Million) Market Share by Type (2017-2022)
Table 40. Global HIV Drugs Price (K Units) by Type (2017-2022)
Table 41. Global HIV Drugs Sales (K Units) by Type (2023-2028)
Table 42. Global HIV Drugs Sales Share by Type (2023-2028)
Table 43. Global HIV Drugs Revenue (US$ Million) Market Share by Type (2023-2028)
Table 44. Global HIV Drugs Revenue Share by Type (2023-2028)
Table 45. Global HIV Drugs Price (K Units) by Type (2023-2028)
Table 46. Global HIV Drugs Sales (K Units) by Application (2017-2022)
Table 47. Global HIV Drugs Sales Share by Application (2017-2022)
Table 48. Global HIV Drugs Revenue (US$ Million) Market Share by Application (2017-2022)
Table 49. Global HIV Drugs Price (K Units) by Application (2017-2022)
Table 50. Global HIV Drugs Sales (K Units) by Application (2023-2028)
Table 51. Global HIV Drugs Sales Share by Application (2023-2028)
Table 52. Global HIV Drugs Revenue (US$ Million) Market Share by Application (2023-2028)
Table 53. Global HIV Drugs Revenue Share by Application (2023-2028)
Table 54. Global HIV Drugs Price (K Units) by Application (2023-2028)
Table 55. North America HIV Drugs Sales by Company (2017-2022) & (K Units)
Table 56. North America HIV Drugs Sales Market Share by Company (2017-2022)
Table 57. North America HIV Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 58. North America HIV Drugs Revenue Market Share by Company (2017-2022)
Table 59. North America HIV Drugs Sales by Type (2017-2022) & (K Units)
Table 60. North America HIV Drugs Sales by Type (2023-2028) & (K Units)
Table 61. North America HIV Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 62. North America HIV Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 63. North America HIV Drugs Sales by Application (2017-2022) & (K Units)
Table 64. North America HIV Drugs Sales by Application (2023-2028) & (K Units)
Table 65. North America HIV Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 66. North America HIV Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 67. North America HIV Drugs Sales by Country (2017-2022) & (K Units)
Table 68. North America HIV Drugs Sales by Country (2023-2028) & (K Units)
Table 69. North America HIV Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 70. North America HIV Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 71. Europe HIV Drugs Sales by Company (2017-2022) & (K Units)
Table 72. Europe HIV Drugs Sales Market Share by Company (2017-2022)
Table 73. Europe HIV Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 74. Europe HIV Drugs Revenue Market Share by Company (2017-2022)
Table 75. Europe HIV Drugs Sales by Type (2017-2022) & (K Units)
Table 76. Europe HIV Drugs Sales by Type (2023-2028) & (K Units)
Table 77. Europe HIV Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 78. Europe HIV Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 79. Europe HIV Drugs Sales by Application (2017-2022) & (K Units)
Table 80. Europe HIV Drugs Sales by Application (2023-2028) & (K Units)
Table 81. Europe HIV Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 82. Europe HIV Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 83. Europe HIV Drugs Sales by Country (2017-2022) & (K Units)
Table 84. Europe HIV Drugs Sales by Country (2023-2028) & (K Units)
Table 85. Europe HIV Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 86. Europe HIV Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 87. Asia Pacific HIV Drugs Sales by Company (2017-2022) & (K Units)
Table 88. Asia Pacific HIV Drugs Sales Market Share by Company (2017-2022)
Table 89. Asia Pacific HIV Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 90. Asia Pacific HIV Drugs Revenue Market Share by Company (2017-2022)
Table 91. Asia Pacific HIV Drugs Sales by Type (2017-2022) & (K Units)
Table 92. Asia Pacific HIV Drugs Sales by Type (2023-2028) & (K Units)
Table 93. Asia Pacific HIV Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 94. Asia Pacific HIV Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 95. Asia Pacific HIV Drugs Sales by Application (2017-2022) & (K Units)
Table 96. Asia Pacific HIV Drugs Sales by Application (2023-2028) & (K Units)
Table 97. Asia Pacific HIV Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 98. Asia Pacific HIV Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 99. Asia Pacific HIV Drugs Sales by Region (2017-2022) & (K Units)
Table 100. Asia Pacific HIV Drugs Sales by Region (2023-2028) & (K Units)
Table 101. Asia Pacific HIV Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 102. Asia Pacific HIV Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 103. Latin America HIV Drugs Sales by Company (2017-2022) & (K Units)
Table 104. Latin America HIV Drugs Sales Market Share by Company (2017-2022)
Table 105. Latin America HIV Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 106. Latin America HIV Drugs Revenue Market Share by Company (2017-2022)
Table 107. Latin America HIV Drugs Sales by Type (2017-2022) & (K Units)
Table 108. Latin America HIV Drugs Sales by Type (2023-2028) & (K Units)
Table 109. Latin America HIV Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 110. Latin America HIV Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 111. Latin America HIV Drugs Sales by Application (2017-2022) & (K Units)
Table 112. Latin America HIV Drugs Sales by Application (2023-2028) & (K Units)
Table 113. Latin America HIV Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 114. Latin America HIV Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 115. Latin America HIV Drugs Sales by Country (2017-2022) & (K Units)
Table 116. Latin America HIV Drugs Sales by Country (2023-2028) & (K Units)
Table 117. Latin America HIV Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 118. Latin America HIV Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 119. Middle East and Africa HIV Drugs Sales by Company (2017-2022) & (K Units)
Table 120. Middle East and Africa HIV Drugs Sales Market Share by Company (2017-2022)
Table 121. Middle East and Africa HIV Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 122. Middle East and Africa HIV Drugs Revenue Market Share by Company (2017-2022)
Table 123. Middle East and Africa HIV Drugs Sales by Type (2017-2022) & (K Units)
Table 124. Middle East and Africa HIV Drugs Sales by Type (2023-2028) & (K Units)
Table 125. Middle East and Africa HIV Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 126. Middle East and Africa HIV Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 127. Middle East and Africa HIV Drugs Sales by Application (2017-2022) & (K Units)
Table 128. Middle East and Africa HIV Drugs Sales by Application (2023-2028) & (K Units)
Table 129. Middle East and Africa HIV Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 130. Middle East and Africa HIV Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 131. Middle East and Africa HIV Drugs Sales by Country (2017-2022) & (K Units)
Table 132. Middle East and Africa HIV Drugs Sales by Country (2023-2028) & (K Units)
Table 133. Middle East and Africa HIV Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 134. Middle East and Africa HIV Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 135. Bristol-Myers Squibb Corporation Information
Table 136. Bristol-Myers Squibb Description and Overview
Table 137. Bristol-Myers Squibb HIV Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 138. Bristol-Myers Squibb HIV Drugs Product and Services
Table 139. Bristol-Myers Squibb HIV Drugs SWOT Analysis
Table 140. Bristol-Myers Squibb Recent Developments
Table 141. Gilead Sciences Corporation Information
Table 142. Gilead Sciences Description and Overview
Table 143. Gilead Sciences HIV Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 144. Gilead Sciences HIV Drugs Product and Services
Table 145. Gilead Sciences HIV Drugs SWOT Analysis
Table 146. Gilead Sciences Recent Developments
Table 147. GlaxoSmithKline Corporation Information
Table 148. GlaxoSmithKline Description and Overview
Table 149. GlaxoSmithKline HIV Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 150. GlaxoSmithKline HIV Drugs Product and Services
Table 151. GlaxoSmithKline HIV Drugs SWOT Analysis
Table 152. GlaxoSmithKline Recent Developments
Table 153. Johnson & Johnson Corporation Information
Table 154. Johnson & Johnson Description and Overview
Table 155. Johnson & Johnson HIV Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 156. Johnson & Johnson HIV Drugs Product and Services
Table 157. Johnson & Johnson HIV Drugs SWOT Analysis
Table 158. Johnson & Johnson Recent Developments
Table 159. Merck Corporation Information
Table 160. Merck Description and Overview
Table 161. Merck HIV Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 162. Merck HIV Drugs Product and Services
Table 163. Merck HIV Drugs SWOT Analysis
Table 164. Merck Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. HIV Drugs Distributors List
Table 168. HIV Drugs Customers List
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. HIV Drugs Product Picture
Figure 2. Global HIV Drugs Sales Market Share by Type in 2021 & 2028
Figure 3. Multi-Class Combination Products Product Picture
Figure 4. Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 5. Non-Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 6. Protease Inhibitors Product Picture
Figure 7. Fusion Inhibitors Product Picture
Figure 8. Entry Inhibitors - CCR5 Co-Receptor Antagonist Product Picture
Figure 9. HIV Integrase Strand Transfer Inhibitors Product Picture
Figure 10. Global HIV Drugs Sales Market Share by Application in 2021 & 2028
Figure 11. Hospital Pharmacies Use Case
Figure 12. Retail Pharmacies Use Case
Figure 13. Online Pharmacies Use Case
Figure 14. Others Use Case
Figure 15. HIV Drugs Report Years Considered
Figure 16. Global HIV Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global HIV Drugs Market Size 2017-2028 (US$ Million)
Figure 18. Global HIV Drugs Sales (2017-2022) & (K Units)
Figure 19. Global HIV Drugs Market Size Market Share by Region: 2021 VS 2028
Figure 20. Global HIV Drugs Sales Market Share by Region (2017-2022)
Figure 21. Global HIV Drugs Sales Market Share by Region in 2021
Figure 22. Global HIV Drugs Revenue Market Share by Region in 2017 VS 2021
Figure 23. Global HIV Drugs Sales Share by Manufacturers in 2021
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by HIV Drugs Sales in 2021
Figure 25. HIV Drugs Revenue Share by Manufacturers in 2021
Figure 26. HIV Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 27. Global HIV Drugs Revenue Share by Type (2017-2022)
Figure 28. Global HIV Drugs Revenue Growth Rate by Type in 2017 & 2021
Figure 29. Global HIV Drugs Revenue Share by Application (2017-2022)
Figure 30. Global HIV Drugs Revenue Growth Rate by Application in 2017 & 2021
Figure 31. North America HIV Drugs Sales Market Share by Type (2017-2028)
Figure 32. North America HIV Drugs Revenue Market Share by Type (2017-2028)
Figure 33. North America HIV Drugs Sales Market Share by Application (2017-2028)
Figure 34. North America HIV Drugs Revenue Market Share by Application (2017-2028)
Figure 35. North America HIV Drugs Sales Share by Country (2017-2028)
Figure 36. North America HIV Drugs Revenue Share by Country (2017-2028)
Figure 37. U.S. HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 38. Canada HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 39. Europe HIV Drugs Sales Market Share by Type (2017-2028)
Figure 40. Europe HIV Drugs Revenue Market Share by Type (2017-2028)
Figure 41. Europe HIV Drugs Sales Market Share by Application (2017-2028)
Figure 42. Europe HIV Drugs Revenue Market Share by Application (2017-2028)
Figure 43. Europe HIV Drugs Sales Share by Country (2017-2028)
Figure 44. Europe HIV Drugs Revenue Share by Country (2017-2028)
Figure 45. Germany HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. France HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. U.K. HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. Italy HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. Russia HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Asia Pacific HIV Drugs Sales Market Share by Type (2017-2028)
Figure 51. Asia Pacific HIV Drugs Revenue Market Share by Type (2017-2028)
Figure 52. Asia Pacific HIV Drugs Sales Market Share by Application (2017-2028)
Figure 53. Asia Pacific HIV Drugs Revenue Market Share by Application (2017-2028)
Figure 54. Asia Pacific HIV Drugs Sales Share by Region (2017-2028)
Figure 55. Asia Pacific HIV Drugs Revenue Share by Region (2017-2028)
Figure 56. China HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. Japan HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. South Korea HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. India HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Australia HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Taiwan HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Indonesia HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Thailand HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Malaysia HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Philippines HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Vietnam HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America HIV Drugs Sales Market Share by Type (2017-2028)
Figure 68. Latin America HIV Drugs Revenue Market Share by Type (2017-2028)
Figure 69. Latin America HIV Drugs Sales Market Share by Application (2017-2028)
Figure 70. Latin America HIV Drugs Revenue Market Share by Application (2017-2028)
Figure 71. Latin America HIV Drugs Sales Share by Country (2017-2028)
Figure 72. Latin America HIV Drugs Revenue Share by Country (2017-2028)
Figure 73. Mexico HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa HIV Drugs Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa HIV Drugs Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa HIV Drugs Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa HIV Drugs Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa HIV Drugs Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa HIV Drugs Revenue Share by Country (2017-2028)
Figure 82. Turkey HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E HIV Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. HIV Drugs Value Chain
Figure 86. HIV Drugs Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Abacavir Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Abacavir market: According to our latest research, the global Abacavir market looks promising in the next 5 years. As of 2022, the global Abacavir market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Abacavir market, with a systematical descriptio......

Global Abacavir Market Research Report 2023

Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 85

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Abacavir market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - GSK - Aurobindo - Novnauki - Smilax - Hycultec - Atripla Segment by Type - Tablet Abacavir - Oral Solution Abacavir S......

Global Zidovudine Market Research Report 2023, Forecast to 2028

Published: 22-Nov-2023        Price: US 2680 Onwards        Pages: 136

Zidovudine is used along with other medications to treat human immunodeficiency virus (HIV) infection. Zidovudine is given to HIV-positive pregnant women to reduce the chance of passing the infection to the baby. Zidovudine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (m......

Global Zidovudine Professional Survey Report 2023, Forecast to 2028

Published: 22-Nov-2023        Price: US 3280 Onwards        Pages: 104

Zidovudine is used along with other medications to treat human immunodeficiency virus (HIV) infection. Zidovudine is given to HIV-positive pregnant women to reduce the chance of passing the infection to the baby. Zidovudine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (m......

Global Abacavir Sulfate Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 29-Aug-2023        Price: US 3380 Onwards        Pages: 127

Market Overview of Global Abacavir Sulfate market: According to our latest research, the global Abacavir Sulfate market looks promising in the next 5 years. As of 2022, the global Abacavir Sulfate market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Abacavir Sulfate market......

Global Zidovudine Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 75

Zidovudine (ZDV), also known as azidothymidine (AZT), is an antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used to prevent mother-to-child spread during birth or after a needlestick injury or other potential exposure. It is sold both by itself and together as lamivudine/zidovudine and abacavir/lamivudine/zidovudine. It can be used by mouth or by slow injection into a vein. The global Zidovudin......

Global HIV Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 93

HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population. The global HIV Drugs market is projected to grow from US$ 23910 million in 2023 to US$ 26950 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.0% during the forecast period.......

HIV Treatment Drugs Industry Forecasts - China Focus

Published: 24-Jul-2023        Price: US 1800 Onwards        Pages: 91

This study focuses on China's HIV Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......

HIV Treatment Drugs Markets in China

Published: 24-Jul-2023        Price: US 4000 Onwards        Pages: 225

China's demand for HIV Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, ind......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs